120 related articles for article (PubMed ID: 21204728)
21. The endogenous reactive oxygen species promote NF-kappaB activation by targeting on activation of NF-kappaB-inducing kinase in oral squamous carcinoma cells.
Wang Y; Huang X; Cang H; Gao F; Yamamoto T; Osaki T; Yi J
Free Radic Res; 2007 Sep; 41(9):963-71. PubMed ID: 17729113
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen peroxide-mediated inhibition of lipopolysaccharide-stimulated inhibitory kappa B kinase activity in rat aortic smooth muscle cells.
Torrie LJ; MacKenzie CJ; Paul A; Plevin R
Br J Pharmacol; 2001 Sep; 134(2):393-401. PubMed ID: 11564658
[TBL] [Abstract][Full Text] [Related]
23. NF-κB-inducing kinase is essential for B-cell maintenance in mice.
Hahn M; Macht A; Waisman A; Hövelmeyer N
Eur J Immunol; 2016 Mar; 46(3):732-41. PubMed ID: 26593098
[TBL] [Abstract][Full Text] [Related]
24. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
[TBL] [Abstract][Full Text] [Related]
25. NF-κB inducing kinase: a key regulator in the immune system and in cancer.
Thu YM; Richmond A
Cytokine Growth Factor Rev; 2010 Aug; 21(4):213-26. PubMed ID: 20685151
[TBL] [Abstract][Full Text] [Related]
26. Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer.
Pflug KM; Sitcheran R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187137
[TBL] [Abstract][Full Text] [Related]
27. A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas.
Gehlhausen JR; Hawley E; Wahle BM; He Y; Edwards D; Rhodes SD; Lajiness JD; Staser K; Chen S; Yang X; Yuan J; Li X; Jiang L; Smith A; Bessler W; Sandusky G; Stemmer-Rachamimov A; Stuhlmiller TJ; Angus SP; Johnson GL; Nalepa G; Yates CW; Wade Clapp D; Park SJ
Hum Mol Genet; 2019 Feb; 28(4):572-583. PubMed ID: 30335132
[TBL] [Abstract][Full Text] [Related]
28. NF-κB dysregulation in multiple myeloma.
Matthews GM; de Matos Simoes R; Dhimolea E; Sheffer M; Gandolfi S; Dashevsky O; Sorrell JD; Mitsiades CS
Semin Cancer Biol; 2016 Aug; 39():68-76. PubMed ID: 27544796
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential.
Yamato A; Soda M; Ueno T; Kojima S; Sonehara K; Kawazu M; Sai E; Yamashita Y; Nagase T; Mano H
Cancer Sci; 2015 Sep; 106(9):1137-42. PubMed ID: 26094954
[TBL] [Abstract][Full Text] [Related]
30. Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma.
Fuchs O
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):16-34. PubMed ID: 23534949
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the binding pattern of NIK inhibitors by computational simulation.
Tang Y
J Biomol Struct Dyn; 2024 Apr; 42(7):3318-3331. PubMed ID: 37183664
[TBL] [Abstract][Full Text] [Related]
32. The NIK of time for B cells.
Myles A; Cancro MP
Eur J Immunol; 2016 Mar; 46(3):547-51. PubMed ID: 26873522
[TBL] [Abstract][Full Text] [Related]
33. NF-κB-inducing kinase maintains mitochondrial efficiency and systemic metabolic homeostasis.
Pflug KM; Lee DW; Keeney JN; Sitcheran R
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166682. PubMed ID: 36878304
[TBL] [Abstract][Full Text] [Related]
34. The Therapeutic Potential of Targeting NIK in B Cell Malignancies.
Haselager MV; Eldering E
Front Immunol; 2022; 13():930986. PubMed ID: 35911754
[TBL] [Abstract][Full Text] [Related]
35. NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes.
Xiao P; Takiishi T; Violato NM; Licata G; Dotta F; Sebastiani G; Marselli L; Singh SP; Sze M; Van Loo G; Dejardin E; Gurzov EN; Cardozo AK
Cell Death Dis; 2022 May; 13(5):476. PubMed ID: 35589698
[TBL] [Abstract][Full Text] [Related]
36. Activation of NF-κB-Inducing Kinase in Islet β Cells Causes β Cell Failure and Diabetes.
Li X; Wu Y; Song Y; Ding N; Lu M; Jia L; Zhao Y; Liu M; Chen Z
Mol Ther; 2020 Nov; 28(11):2430-2441. PubMed ID: 32730745
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB-inducing kinase in cancer.
Maubach G; Feige MH; Lim MCC; Naumann M
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):40-49. PubMed ID: 30419317
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional induction of NF-κB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells.
Pflug KM; Lee DW; McFadden K; Herrera L; Sitcheran R
Sci Rep; 2023 Aug; 13(1):13093. PubMed ID: 37567906
[TBL] [Abstract][Full Text] [Related]
39. The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.
Vrábel D; Pour L; Ševčíková S
Blood Rev; 2019 Mar; 34():56-66. PubMed ID: 30501907
[TBL] [Abstract][Full Text] [Related]
40. Kinase domain activation through gene rearrangement in multiple myeloma.
Morgan GJ; He J; Tytarenko R; Patel P; Stephens OW; Zhong S; Deshpande S; Bauer M; Weinhold N; Schinke C; Rasche L; Bailey M; Ali S; Ross J; Miller VA; Stephens P; Thanendrarajan S; Zangari M; van Rhee F; Mughal T; Davies FE; Walker BA
Leukemia; 2018 Nov; 32(11):2435-2444. PubMed ID: 29654269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
